Autistic Disorder
|
0.460 |
Biomarker
|
disease |
CTD_human |
All together, our results indicate that mutations in IL1RAPL1 cause a spectrum of neurological impairments ranging from MR to high functioning autism.
|
18801879 |
2008 |
Autistic Disorder
|
0.460 |
GeneticVariation
|
disease |
BEFREE |
Furthermore, we identified by comparative genomic hybridization a large intragenic deletion of exons 3-7 of IL1RAPL1 in three brothers with autism and/or MR.
|
18801879 |
2008 |
Autistic Disorder
|
0.460 |
Biomarker
|
disease |
HPO |
|
|
|
Autism Spectrum Disorders
|
0.360 |
Biomarker
|
disease |
BEFREE |
In this review, we summarize all the major data describing the synaptic and neuronal functions of IL1RAPL1 and recapitulate most of the genetic deletion identified in humans and associated to intellectual disability (ID) and autism spectrum disorders (ASD).
|
30548231 |
2019 |
Autism Spectrum Disorders
|
0.360 |
GeneticVariation
|
disease |
BEFREE |
Mutations in interleukin-1 receptor accessory protein like 1 (IL1RAPL1) gene have been associated with non-syndromic intellectual disability (ID) and autism spectrum disorder.
|
25305082 |
2015 |
Autism Spectrum Disorders
|
0.360 |
Biomarker
|
disease |
BEFREE |
Interleukin-1 receptor accessory protein-like 1 (IL1RAPL1) is associated with X-linked mental retardation and autism spectrum disorder.
|
23785489 |
2013 |
Autism Spectrum Disorders
|
0.360 |
GeneticVariation
|
disease |
BEFREE |
Intragenic deletions of IL1RAPL1, only rarely identified, have mostly been associated with nonspecific intellectual disability (IDX) and autism spectrum disorder.
|
23613341 |
2013 |
Autism Spectrum Disorders
|
0.360 |
Biomarker
|
disease |
CTD_human |
Systematic resequencing of X-chromosome synaptic genes in autism spectrum disorder and schizophrenia.
|
20479760 |
2011 |
Autism Spectrum Disorders
|
0.360 |
GeneticVariation
|
disease |
BEFREE |
In conclusion, coding changes of the IL1RAPL1 gene do not appear to be associated with ASD in selected AGRE families with linkage evidence to the chromosome Xp22.11-p21.2 region.
|
21491612 |
2011 |
Autism Spectrum Disorders
|
0.360 |
GeneticVariation
|
disease |
BEFREE |
Mutations in IL1RAPL1 have recently been associated with autism spectrum disorders and a missense mutation (R102Q) on NCS-1 has been found in one individual with autism.
|
20479890 |
2010 |
melanoma
|
0.310 |
Biomarker
|
disease |
BEFREE |
MRX34, a liposome-formulated miRNA-34 mimic, developed by Mirna Therapeutics, becomes the first microRNA therapeutic entering clinical trial for the treatment of hepatocellular carcinoma, renal cell carcinoma, and melanoma.
|
27988500 |
2017 |
melanoma
|
0.310 |
Biomarker
|
disease |
CTD_human |
Aggressiveness of human melanoma xenograft models is promoted by aneuploidy-driven gene expression deregulation.
|
22535842 |
2012 |
Schizophrenia and related disorders
|
0.310 |
Biomarker
|
group |
PSYGENET |
Copy number variants thought to be associated with risk for schizophrenia and related disorders also occur in affected individuals in Palau, specifically 15q11.2 and 1q21.1 deletions, partial duplication of IL1RAPL1 (Xp21.3), and chromosome X duplications (Klinefelter's syndrome).
|
21982423 |
2011 |
Schizophrenia and related disorders
|
0.310 |
GeneticVariation
|
group |
BEFREE |
Copy number variants thought to be associated with risk for schizophrenia and related disorders also occur in affected individuals in Palau, specifically 15q11.2 and 1q21.1 deletions, partial duplication of IL1RAPL1 (Xp21.3), and chromosome X duplications (Klinefelter's syndrome).
|
21982423 |
2011 |
Mental Retardation, X-Linked 1
|
0.310 |
Biomarker
|
disease |
BEFREE |
Our data further confirm the importance and usefulness of linkage studies for gene mapping in MRX families and demonstrate that IL1RAPL1 plays an important role in the etiology of MRX.
|
19012350 |
2008 |
Mental Retardation, X-Linked 1
|
0.310 |
GermlineCausalMutation
|
disease |
ORPHANET |
Our data further confirm the importance and usefulness of linkage studies for gene mapping in MRX families and demonstrate that IL1RAPL1 plays an important role in the etiology of MRX.
|
19012350 |
2008 |
Mental Retardation, X-Linked 1
|
0.310 |
GermlineCausalMutation
|
disease |
ORPHANET |
A truncating mutation in the IL1RAPL1 gene is responsible for X-linked mental retardation in the MRX21 family.
|
16470793 |
2006 |
MENTAL RETARDATION, X-LINKED 34 (disorder)
|
0.300 |
Biomarker
|
disease |
CLINGEN |
The X-Linked Intellectual Disability Protein IL1RAPL1 Regulates Dendrite Complexity.
|
28576939 |
2017 |
MENTAL RETARDATION, X-LINKED 34 (disorder)
|
0.300 |
Biomarker
|
disease |
CLINGEN |
De novo loss-of-function mutations in SETD5, encoding a methyltransferase in a 3p25 microdeletion syndrome critical region, cause intellectual disability.
|
24680889 |
2014 |
MENTAL RETARDATION, X-LINKED 34 (disorder)
|
0.300 |
Biomarker
|
disease |
CLINGEN |
Novel mutation of IL1RAPL1 gene in a nonspecific X-linked mental retardation (MRX) family.
|
19012350 |
2008 |
MENTAL RETARDATION, X-LINKED 34 (disorder)
|
0.300 |
Biomarker
|
disease |
CLINGEN |
Mutations in the calcium-related gene IL1RAPL1 are associated with autism.
|
18801879 |
2008 |
MENTAL RETARDATION, X-LINKED 34 (disorder)
|
0.300 |
Biomarker
|
disease |
CLINGEN |
A truncating mutation in the IL1RAPL1 gene is responsible for X-linked mental retardation in the MRX21 family.
|
16470793 |
2006 |
MENTAL RETARDATION, X-LINKED 34 (disorder)
|
0.300 |
Biomarker
|
disease |
CLINGEN |
A new member of the IL-1 receptor family highly expressed in hippocampus and involved in X-linked mental retardation.
|
10471494 |
1999 |
Mental Retardation
|
0.180 |
Biomarker
|
disease |
BEFREE |
IL1RAPL1 associated with mental retardation and autism regulates the formation and stabilization of glutamatergic synapses of cortical neurons through RhoA signaling pathway.
|
23785489 |
2013 |
Mental Retardation
|
0.180 |
Biomarker
|
disease |
BEFREE |
It is especially helpful for IL1RAPL1 deletion detection as no clinical markers for MR are available.
|
22456342 |
2012 |